Literature DB >> 4393968

[Australia antigen, virus hepatitis and periarteritis nodosa].

C Trepo, J Thivolet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4393968

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  12 in total

Review 1.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 2.  Infection-related vasculitis.

Authors:  Omondi Oyoo; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

3.  Extrahepatic manifestations of acute hepatitis B virus infection.

Authors:  Matthew R Kappus; Richard K Sterling
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

Review 4.  Vasculitides associated with HIV infection.

Authors:  R Chetty
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

5.  Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases.

Authors:  T Michalak
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

6.  Vasculitis.

Authors:  M D Lockshin
Journal:  Bull N Y Acad Med       Date:  1979-10

7.  Complications of viral hepatitis.

Authors:  G A Martini; G Baltzer
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

8.  The proteins of the aqueous humour.

Authors:  J P Dernouchamps
Journal:  Doc Ophthalmol       Date:  1982-11-01       Impact factor: 2.379

9.  The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa.

Authors:  C G Trepo; A J Zucherman; R C Bird; A M Prince
Journal:  J Clin Pathol       Date:  1974-11       Impact factor: 3.411

Review 10.  Kaleidoscope of autoimmune diseases in HIV infection.

Authors:  Justyna Roszkiewicz; Elzbieta Smolewska
Journal:  Rheumatol Int       Date:  2016-08-20       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.